6881
COM:VAZYME
诺唯赞
- Stock
Last Close
23.50
25/11 07:00
Market Cap
8.03B
Beta: -
Volume Today
2.19M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 22.37M - | 40.92M 82.95% | 92.93M 127.10% | 187.28M 101.52% | 303.19M 61.89% | |||
average payables | 9.32M - | 14.87M 59.57% | 37.79M 154.16% | 88.67M 134.63% | 218.77M 146.73% | |||
average receivables | 38.78M - | 62.32M 60.71% | 158.90M 154.96% | 293.09M 84.45% | 629.45M 114.76% | |||
book value per share | 0.42 - | 0.47 10.12% | 3.75 - | 11.38 203.80% | 11.56 1.56% | |||
capex per share | -0.05 - | -0.09 70.73% | -0.43 - | -0.72 68.42% | -2.41 234.29% | |||
capex to depreciation | -7.19 - | -7.32 1.75% | -2.76 62.33% | -11.11 303.01% | -4.74 57.35% | -7.89 66.40% | ||
capex to operating cash flow | 4.88 - | 8.03 64.80% | -1.31 116.28% | -0.19 85.48% | -0.42 123.72% | -1.31 208.38% | ||
capex to revenue | -0.17 - | -0.19 12.32% | -0.07 60.62% | -0.10 31.62% | -0.14 43.78% | -0.27 92.44% | ||
cash per share | 0.25 - | 0.23 6.22% | 2.86 - | 9.52 232.95% | 8.18 14.05% | |||
days of inventory on hand | 267.32 - | 346.67 29.69% | 463.98 33.84% | 361.55 22.08% | 251.96 30.31% | 119.70 52.49% | ||
days payables outstanding | 96.20 - | 155.79 61.93% | 147.43 5.36% | 160.01 8.53% | 123.55 22.79% | 104.78 15.19% | ||
days sales outstanding | 97.91 - | 101.32 3.48% | 105.03 3.66% | 56.13 46.56% | 67.51 20.28% | 93.40 38.36% | ||
debt to assets | 0.03 - | 0.12 322.31% | 0.11 11.45% | 0.00 99.35% | 0.02 2,671.77% | 0.08 285.47% | ||
debt to equity | 0.04 - | 0.19 410.44% | 0.18 4.90% | 0.00 99.52% | 0.02 2,457.86% | 0.10 349.94% | ||
dividend yield | 0.00 - | 0.00 198.68% | 0.00 - | 0.00 141.75% | 0.01 5,296.92% | |||
earnings yield | 0.00 - | 0.00 71.50% | 0.03 - | 0.02 34.82% | 0.03 58.94% | |||
enterprise value | 30.28B - | 30.31B 0.10% | -58.08M 100.19% | 30.14B 51,991.22% | 37.06B 22.96% | 20.11B 45.75% | ||
enterprise value over ebitda | 5.96K - | 3.45K 42.08% | -1.64 100.05% | 29.21 1,883.93% | 42.61 45.86% | 15.23 64.27% | ||
ev to operating cash flow | -7.84K - | -7.58K 3.38% | -3.82 99.95% | 37.51 1,081.73% | 60.09 60.19% | 27.35 54.48% | ||
ev to sales | 269.44 - | 177.45 34.14% | -0.22 100.12% | 19.27 9,001.87% | 19.83 2.95% | 5.63 71.59% | ||
free cash flow per share | -0.06 - | -0.10 59.31% | 1.83 - | 0.98 46.55% | -0.57 158.36% | |||
free cash flow yield | -0.00 - | -0.00 59.31% | 0.02 - | 0.01 56.96% | -0.01 216.41% | |||
graham net net | 0.23 - | 0.14 41.06% | 2.77 - | 9.25 234.09% | 6.86 25.76% | |||
graham number | 0.31 - | 0.18 43.98% | 13.95 - | 21.88 56.82% | 19.68 10.04% | |||
income quality | -1.06 - | -3.85 263.51% | 0.59 115.31% | 0.98 65.92% | 0.91 7.01% | 1.24 36.22% | ||
intangibles to total assets | 0.00 - | 0.00 28.27% | 0.01 156.80% | 0.00 34.90% | 0.00 21.52% | 0.03 730.26% | 0 100% | |
interest coverage | 0.02 - | 0.58 3,747.38% | 60.47 10,263.05% | 947.03 1,466.15% | 199.59 78.92% | 96.07 51.87% | ||
interest debt per share | 0.02 - | 0.09 448.82% | 0.01 - | 0.26 4,179.30% | 1.18 350.33% | |||
inventory turnover | 1.37 - | 1.05 22.89% | 0.79 25.28% | 1.01 28.33% | 1.45 43.50% | 3.05 110.48% | ||
invested capital | 0.04 - | 0.19 410.44% | 0.18 4.90% | 0.00 99.52% | 0.02 2,457.86% | 0.10 349.94% | ||
market cap | 30.36B - | 30.36B 0% | 30.36B - | 38.45B 26.64% | 21.19B 44.88% | |||
net current asset value | 106.64M - | 90.97M 14.69% | 108.27M 19.02% | 1.12B 931.11% | 3.57B 219.87% | 3.17B 11.17% | ||
net debt to ebitda | -16.40 - | -5.94 63.78% | -1.64 72.43% | -0.21 86.95% | -1.59 646.12% | -0.82 48.40% | ||
net income per share | 0.01 - | 0.00 71.50% | 2.31 - | 1.87 19.05% | 1.49 20.32% | |||
operating cash flow per share | -0.01 - | -0.01 3.60% | 2.26 - | 1.70 24.72% | 1.84 8.40% | |||
payables turnover | 3.79 - | 2.34 38.25% | 2.48 5.67% | 2.28 7.86% | 2.95 29.51% | 3.48 17.91% | ||
receivables turnover | 3.73 - | 3.60 3.37% | 3.48 3.53% | 6.50 87.13% | 5.41 16.86% | 3.91 27.72% | ||
research and ddevelopement to revenue | 0.23 - | 0.31 32.69% | 0.23 25.20% | 0.08 65.43% | 0.12 53.61% | 0.11 9.96% | 0.26 136.77% | |
return on tangible assets | 0.02 - | 0.00 78.61% | 0.08 1,828.27% | 0.51 539.50% | 0.15 71.15% | 0.10 30.96% | ||
revenue per share | 0.32 - | 0.48 52.00% | 4.40 - | 5.15 17.14% | 8.95 73.71% | |||
roe | 0.02 - | 0.01 74.12% | 0.13 1,961.96% | 0.62 378.24% | 0.16 73.35% | 0.13 21.55% | ||
roic | 0.02 - | 0.01 71.39% | 0.11 1,537.88% | 0.63 472.33% | 0.16 74.41% | 0.22 40.50% | ||
sales general and administrative to revenue | 0.11 - | 0.07 32.15% | 0.07 6.62% | 0.03 49.09% | 0.05 33.88% | 0.03 35.81% | ||
shareholders equity per share | 0.42 - | 0.47 10.12% | 3.75 - | 11.38 203.80% | 11.56 1.56% | |||
stock based compensation to revenue | ||||||||
tangible asset value | 150.10M - | 165.39M 10.19% | 197.72M 19.55% | 1.32B 570.09% | 4.11B 210.25% | 4.43B 7.82% | ||
tangible book value per share | 0.42 - | 0.46 10.19% | 3.72 - | 11.33 204.27% | 11.11 1.94% | |||
working capital | 108.19M - | 95.61M 11.62% | 124.09M 29.79% | 1.16B 831.93% | 3.66B 216.79% | 3.41B 6.89% |
All numbers in CNY (except ratios and percentages)